SHANGHAI SHENQI PHARMACEUTICAL INVESTMENT MANAGEMENT financial statements, including revenue, expenses, profit, and loss

The total revenue of 900904 for the last quarter is 78.54 M USD, and it's 14.14% higher compared to the previous quarter. The net income of Q1 24 is 3.33 M USD.